LiliumX, an innovative BioTech start-up focused on the development of next generation antibody-based therapeutics, has unveiled its new brand name, and welcomed three top industry leaders to the business, after securing $7.8 million in investment. Established in 2021 by co-founders Arne Scheu and Irsyad Khairil, following their own research into “LEGO” protein technologies when studying […]
The post LiliumX unveils rebrand as Valink Therapeutics and appointment of new board and executives, after securing $7.8 million in investment appeared first on UK Tech News.
